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http://dxBackground: Surgical aortic valve replacement is being increasingly performed in elderly patients with good
perioperative outcomes and long-term survival. Evidence is limited on health-related quality of life after aortic
valve replacement, which is an important measure of operative success in the elderly.
Methods: A systematic review of clinical studies after January 2000 was performed to identify health-related
quality of life in the elderly after aortic valve replacement. Strict inclusion and exclusion criteria were applied.
Quality appraisal of each study also was performed using predefined criteria. Health-related quality of life
results were synthesized through a narrative review with full tabulation of the results of all included studies.
Results: Health-related quality of life improvements were shown across most or all domains in different
health-related quality of life instruments. Elderly patients experienced marked symptomatic improvement.
Health-related quality of life was equivalent or superior to both an age-matched population and younger patients
undergoing identical procedures. There were excellent functional gains after surgery, but elderly patients remain
susceptible to geriatric issues and mood problems. Concomitant coronary artery bypass did not affect health-
related quality of life. There was a diverse range of study designs, methods, and follow-up times that limited
direct comparison between studies.
Conclusions:Aortic valve replacement results in significant health-related quality of life benefits across a broad
range of health domains in elderly patients. Age alone should not be a precluding factor for surgery. Data are
heterogeneous and mostly retrospective. We recommend future studies based on consistent guidelines provided
in this systematic review. (J Thorac Cardiovasc Surg 2013;145:1173-89)According to the United Nations Population Division, the
world’s population is aging at a rapid and unprecedented
rate that is expected to persist at least until 2050.1Within de-
veloped countries, the proportion of people aged more than
60 years is projected to double from 11% to 22% (2 billion
people) by 2050.1 By 2025, people aged more than 65 years
will account for 21.3% of the population.1 The number of
very elderly people aged more than 80 years is projected
to increase by a factor of 26 compared with a factor of 10
and 3.7 for those agedmore than 60 years and the total world
population, respectively.1 The increasingly aging popula-
tion will create an increased demand for treatment of degen-
erative aortic valve diseases, the most common site of
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The Journal of Thoracic and Carpopulation aged more than 65 years will have aortic
sclerosis,2,4 and 9% of these patients will progress to
aortic stenosis over 5 years.5 A large population study esti-
mates a prevalence of 2.8% for aortic stenosis and 2.0% for
aortic regurgitation in those aged more than 75 years.6
Aortic stenosis has a dismal natural course and remains
one of the most common causes of morbidity and mortality
in the elderly.7 Without surgical intervention, 2-year mor-
tality rates reach 90% in symptomatic patients, which is
a 12-fold increased mortality risk compared with surgically
treated patients.8-10 Attempts at conservative treatment also
are largely unsuccessful.11 Rapidly improving surgical
standards and postoperative care have resulted in improved
survival while maintaining low operative mortality after
aortic valve replacement (AVR) in the elderly.2,10,12-15
Despite good operativemorbidity andmortality, these pa-
rameters alone do not give enough information on a patient’s
physical, functional, emotional, and mental well-being.16
Postoperative health-related quality of life (HRQOL) is
a primary goal of surgery in the elderly and an important as-
pect for many patients in their decision-making.17 The chal-
lenge of surgery in this population is to provide a good
HRQOL in the mid- to long-term. Evidence is accumulating
on the positive HRQOL outcomes after AVR,8,12,14,15,18-32
and it remains the only effective treatment option for
aortic valve disease.29 AVR is also highly cost-effective in
the elderly population,33 yet it is still withheld from elderlydiovascular Surgery c Volume 145, Number 5 1173
Expert Review Shan et al11Abbreviations and Acronyms
AVR ¼ aortic valve replacement
HRQOL ¼ health-related quality of life
NHP ¼ Nottingham Health Profile
NYHA ¼ New York Heart Association
QOL ¼ quality of life
SF-36 ¼ Medical Outcomes Survey
Short-Form 36
WHO ¼World Health Organization74 The Jpatients. Up to one third of patients do not receive necessary
operations7,13,34 despite current guidelines recommending
that all elderly patients with symptomatic aortic stenosis
should be considered for AVR.35 Considering that life ex-
pectancy is 17.1 years at age 65 years and 8.2 years at age
80 years,1 there is a significant opportunity for elderly
patients to improve their HRQOL and survival if they are
offered surgery.
OBJECTIVES
We conducted a systematic review of publications from
the start of this millennium to investigate the effect of
AVR on HRQOL in elderly patients aged more than 70
years. This systematic review aims to (1) summarize the lit-
erature and clarify strengths and weaknesses of current ev-
idence on HRQOL after AVR in the elderly, (2) demonstrate
whether there is a HRQOL benefit in elderly patients after
AVR and whether it is enough to justify surgery, and (3)
outline guidelines for future research.
MATERIALS AND METHODS
The structure of this systematic review followed previously recommen-
ded guidelines36 and was written in accordancewith the PRISMA checklist
for systematic reviews.37
Definition and Measurement of Health-Related
Quality of Life
The World Health Organization (WHO) has defined health as being
‘‘not only the absence of disease and infirmity but also the presence of
physical, mental, and social well-being.’’38 HRQOL encapsulates an indi-
vidual’s physical, emotional, and psychologic health, as well as social and
functional status.39 Because HRQOL is not a tangible entity, a standardized
method of measurement is required that is reliable, valid, responsive, and
sensitive, and that covers all health domains.39
In valvular heart disease, disease-specific quality of life (QOL) mea-
sures aim to accurately reflect a patient’s experience of a specific illness
or its treatment. A common tool is New York Heart Association (NYHA)
classification,40 but the Minnesota Living with Heart Failure Question-
naire41 and Kansas City Cardiomyopathy Questionnaire42 also have been
used. Generic HRQOL instruments are required to facilitate holistic and
quantitative comparisons between different groups of patients. According
to the WHO’s QOL group, any generic HRQOL instrument should include
physical, psychologic, social, functional, and well-being domains.43 Well-
recognized HRQOL instruments in cardiac surgery are the Medicalournal of Thoracic and Cardiovascular SurOutcomes Survey Short-Form 36 (SF-36),44-47 Nottingham Health
Profile (NHP),48,49 EuroQOL (EQ-5D),50 and Medical Outcomes Survey
Short-Form 12.51,52 More detailed descriptions of each scoring system
and HRQOL instrument are shown in Table 1.
Eligibility Criteria
Study characteristics were as follows: (1) elderly patients defined as
aged more than 70 years; (2) greater than 50% operations performed
were AVR or AVR and concomitant CABG; (3) comparisons made with
preoperative status, younger patients undergoing similar procedures, or
an age-matched general population; (4) HRQOL methods of assessment
and results reported; and (5) retrospective and prospective investigative
studies. Report characteristics were (1) publication date during or after
the year 2000, (2) fully published status, and (3) English language.
Literature Search and Information Sources
A literature search was conducted using a MeSH keyword search via
PubMed. Strict inclusion criteria for study characteristics were applied as
described. On August 29, 2012, a search was conducted as described in
Figure 1. A subsequent additional manual search was conducted to identify
studies not covered by the initial MeSH keyword search. These manual
search articles were sourced from the EMBASE, DISCOVERY, and
MEDLINE databases, as well as bibliographies of each included study. Au-
thors were e-mailed when original PDF documents could not be sourced.
Study Selection
Two reviewers screened titles and abstracts after bothMeSHkeyword and
manual searches. Studies were excluded if they did not meet eligibility crite-
ria. If the information required to determine eligibility was not in the abstract,
a second pass was run after data extraction. Reviewers were not blinded.
Data Items and Collection Process
Data extraction was then performed in 2 phases by 2 reviewers using
standardized pilot forms. The first phase involved assessment of study qual-
ity (Table 2), and the second phase collected results of the studies reviewed
(Table 3). All data items were predetermined and specified in these tables.
Assessment of Risk of Bias
Risk of bias in individual studies was mainly assessed by evaluating the
(1) study design, (2) number of patients, (3) use of a generic HRQOL in-
strument, and (4) questionnaire response rates.
RESULTS
After careful systematic selection, 19 studies were in-
cluded in this systematic review.8,12,14,15,18-24,26,28-32,53,54
Full details and results of reviewed articles are provided
in Tables 2 and 3.
Early Mortality
The studies included in this review showed an acceptable
early mortality after AVR (Table 4). Early mortality was
generally low in contemporary studies and in isolated
AVR procedures.
Cardiac-Specific Quality of Life Measures
Elderly patients appear to have marked symptomatic im-
provements after AVR. Within the first 18 months after
operation, only 0% to 20% of patients are in NYHA
III/IV.12,21,29 The improvement in NHYA class persistsgery c May 2013
TABLE 1. Description of scoring systems and health-related quality of life instruments
System Components
MLHFQ41 Effects of heart failure on QOL asked through 21 questions covering physical and emotional dimensions
Physical Lower-limb edema, limiting ambulation, difficulty leaving the house, limiting
occupation, limiting recreational activities, limiting sexual activity, shortness of
breath, fatigue,
hospitalization, treatment side effects,
Emotional insomnia, difficulty relating/interacting with people, eat less foods previously enjoyed,
financial costs, feel like burden to family or friends, feel like losing control of life,
worry, difficulty concentrating or remembering, feeling depressed
NYHA40 Class I No limitations on physical activity, no symptoms with ordinary activity
Class II Slight limitation on physical activity, mild symptoms on ordinary activity
Class III Marked limitation on physical activity, symptomatic at less than ordinary activity levels
Class IV Unable to perform any activity, discomfort with any activity, symptomatic at rest
KCCQ42 There are 23 items measuring self-reported health status in patients with heart failure. Scales measured are physical limitation, symptom
stability, symptom frequency, symptom burden, total symptoms, self-efficacy, QOL, social limitation, overall summary, and clinical
summary.
SF-3644-47
SF-1251,52
36 (or 12) items measuring 8 conceptual domains or dimensions of health:
General health Measurement of perceived overall health, including past and present health
Physical functioning Indicates level of limitations in lifting, bending, kneeling, or walking moderate distance
Bodily pain Represents the intensity, frequency, and duration of bodily pain and limitations in
normal activities due to pain
Mental health Measures the emotional, cognitive, and intellectual status of the patient
Role physical Measures the degree in performing of usual activities for age and social status
Role emotional Measures personal feeling of job performance at work or other activities
Vitality Measures feeling of energy, fatigue, and tiredness
Social functioning Indicates ability to develop and maintain mature social relationships.
The SF-36 scores can be related to activities of daily living. For example, 80% of responders who judged their general health as being
good, very good, or excellent had a score of 61 in the general health scale of SF-36.61
Note: Both SF-36 and SF-12 surveys can provide 2 summary measures—physical component score and mental component score.
NHP48,49 38 yes/no statements on health problems covering 6 dimensions of subjective health:
Physical mobility Only walk indoors, difficult to bend, unable to walk, troublewith stairs, difficult to reach
for things, difficult to dress, hard to stand for long times, needs help walking outside
Pain Pain at night, unbearable pain, pain on movement, pain on walking, pain on standing,
constant pain, pain with stairs, pain on sitting
Sleep Require sleeping tablets, early morning wakening, awake most of the night, takes a long
time to get to sleep, insomnia
Energy level Tiredness, everything is an effort, easily run out of energy
Emotional reactions Feeling down, anhedonia, feeling on edge, day seems to drag, easily lose temper, feel
like losing control, ruminating at night, feel like life is not worth living, wake up
feeling depressed
Social isolation Feeling lonely, difficult to make contact with people, feels close to no one, feel like a
burden to people, difficulty interacting with people
EuroQOL50 5 domains of EQ-5D index:
Mobility Ability to walk
Self-care Ability to dress
Usual activities Activities of daily living
Pain/discomfort Level of pain
Anxiety/depression Level of anxiety of depression
QOL, Quality of life; MLHFQ, Minnesota Living with Heart Failure Questionnaire; NYHA, New York Heart Association; KCCQ, Kansas City Cardiomyopathy Questionnaire;
SF-36, Medical Outcomes Survey Short-Form 36; SF-12, Medical Outcomes Survey Short-Form 12; NHP, Nottingham Health Profile.
Shan et al Expert Reviewlong-term, with 35% to 81.7% less patients in NYHA III/
IV compared with preoperatively.8,18,19,22,23,26,29 Some
studies demonstrate 0% of patients in NYHA III/IV at
follow-up.15,18 Salazar and colleagues29 reported 62.4%,The Journal of Thoracic and Car0%, and 3.8% of patients with a preoperative, 1-year, and
5-year NYHA III/IV, respectively. The eventual increase
inNYHA scores at 5 years is small and consistent with a nat-
ural age-related decline.diovascular Surgery c Volume 145, Number 5 1175
SEARCH ALGORITHM
29/8/2012
MeSH Keywords
“Cardiac Surgical Procedures” AND “Aortic Valve” AND 
“Quality of Life” AND “Elderly”
NOT “Transcatheter” 
Limiters
AND Publication date ≥”2000”, AND Language “English” 
41 ARTICLES IDENTIFIED
35 articles EXCLUDED
6 ARTICLES12,20,21,22,24,31
Studies not relevant for present review, Elderly not 
>70yrs old, reviews, breakdown of procedure types not 
recorded, absent methods or results of HRQOL 
assessment
19 ARTICLES INCLUDED8,12,14,15,18-24,26,28-32,53,54
Being appropriate for this systematic review due to 
relevancy to this topic and scientific accuracy of the 
reported results
PLUS MANUAL SEARCH OF
EMBASE, MEDLINE, DISCOVERY DATABASES AND
BIBLIOGRAPHIES OF EACH INCLUDED STUDY
13 ARTICLES8,14,15,18,19,23,26,28,29,30,32,53,54
FIGURE 1. Search algorithm. HRQOL, Health-related quality of life.
Expert Review Shan et alGeneric Health-Related Quality of Life Instruments
Only 2 authors investigated preoperative compared with
postoperative HRQOL. At 1, 6, and 12 months, elderly pa-
tients had had highly statistical and clinically significant1176 The Journal of Thoracic and Cardiovascular Surimprovements in Medical Outcomes Survey Short-Form
12 and EQ-5D scores compared with their preoperative
status.24,54
Comparison with an age-matched general population
shows that elderly patients have equivalent or superior
HRQOL scores after surgery.12,14,20,23,30,31,53 There were
4 studies published by Vicchio and colleagues14,31,53
included in this review, and all demonstrated
significantly higher SF-36 scores than the age-matched
general population in most or all of the 8 domains. Sundt
and colleagues12 and Lam and Hendry23 corroborate these
results with their finding that octogenarians have better
bodily pain, social function, general health, and mental
health scores than the general elderly population, includ-
ing those 5 years younger. Studies using other HRQOL in-
struments also appear to demonstrate significantly better
scores. Ennker and colleagues20 studied the use of stent-
less bioprosthetic valves in octogenarians and found
NHP scores better in all domains except for energy. A sig-
nificant gender difference was found. Women had a slower
recovery on Minnesota Living with Heart Failure Ques-
tionnaire scores and may benefit from discharge to a con-
valescence resource.30
Elderly patients can achieve a similar or better
HRQOL compared with younger patients undergoing
the same procedure. Lam and Hendry23 found that com-
pared with patients aged less than 80 years, patients
aged more than 80 years had better postoperative bodily
pain, vitality, social function, and mental health
scores and equivalent scores in all other domains on
the SF-36.
Self-Constructed Measures of Quality of Life
Elderly patients derived significant functional gains
from AVR. Up to 90% were able to resume normal activ-
ities for their age,21,29 and most could undertake moderate
to heavy levels of activity.18,19,22 This is reflected by
a large proportion of patients feeling as good as or
better than they did preoperatively,21,22,26 such that
many patients reported they were independent of their
activities of daily living.18,21,26,28 Approximately 100%
of patients were satisfied with their decision to undergo
surgery and would be willing to undergo another
operation.18,19,21,22,26
Maillet and colleagues8 studied frailty and HRQOL in
octogenarians and had less positive results. A lower propor-
tion of patients reported positive general self-rated health or
QOL scores. Only 66.1% of patients considered that their
health had improved since the operation, and 60.7% of pa-
tients would have another AVR. Geriatric parameters, espe-
cially gait problems and falls, reflected a frail cohort of
patients after operation. Self-rated mood also was less opti-
mistic, with half of patients admitting to having ‘‘sad ideas’’
and 33.9% having anhedonia.gery c May 2013
Shan et al Expert ReviewConcomitant Coronary Artery Bypass Grafting
Despite improvement on functional and social domains
of HRQOL being less for AVR compared with CABG,
HRQOL still strongly increases within each procedure
group.24 Furthermore, Vicchio and colleagues24 report no
differences in long-term HRQOL according to the presence
of concomitant CABG.DISCUSSION
Strength of Evidence and Bias
The strength of evidence was analyzed systematically in
this review. Detailed results are shown in Table 2.
Heterogeneous data and lack of quantitative re-
sults12,14,15,20,23 prevented direct comparison of results or
meta-analyses. There was also a variety of patient charac-
teristics. In particular, the proportion of men ranged from
21% to 65.5%. Urgent operations comprised 45.5% of pro-
cedures in the study by Nikolaidis and colleagues,26 and 10
studies did not record this information.8,14,20,21,23,29,30,32,53
Only 2 studies were retrospective.23,54 The retrospective
design has inherent bias and contributes to a lack of data
on whether these patients improved from their
preoperative state and by what magnitude. Small patient
numbers limit the generalizability of these results.
The SF-36 was the most commonly used HRQOL instru-
ment.12,14,23,30-32,53 A validated HRQOL instrument was
not used in 9 studies, which may have resulted in
inadequate coverage of the WHO’s HRQOL
definition.8,15,18,19,21,22,26,28,29 The subjective nature of
a patient’s perception of his or her HRQOL requires
validated HRQOL instruments, such as SF-36 and NHP,
to accurately assess a patient’s HRQOL across all domains.
Despite this, NYHA scores were used in isolation even
though they are not originally designed as HRQOL
instruments.8,12,15,18,19,22,23,26,29,30
According to previous guidelines, a response rate of more
than 85% (loss to follow-up<15%) is considered ideal for
treatment-received analyses.36Only 3 articles did not achieve
thismark.23,26,30 Therewere 4 studies that did not report their
response rates orwere not available because of the inability to
source the original documents.8,18,21,24 Authors were
contacted, but there was no reply. A relatively good follow-
up consistency was demonstrated in the population studied.
This may be attributed to questionnaires administered by
telephone,12,19,20,28,31,53 which are considered to be more
reliable and to have higher response rates than self-
administered postal questionnaires.55 The precision of
HRQOL results is dependent on the confidence interval,
range, or standard error of instrument scores, but only 4 arti-
cles recorded this information.19,20,30,54
Whereas there were abundant data with a late follow-up
time point of greater than 2 years,8,14,15,18-20,22,23,26,28-32,53
evidence on early HRQOL outcomes after AVR remainsThe Journal of Thoracic and Carscarce.12,21,54 Furthermore, 4 studies were published 5 or
more years after the completion of the study period.8,15,23,28
Rapid advances in surgical technique and postoperative
care mean these results may be less reflective of potential
HRQOL benefits with modern operative care.
More well-designed prospective studies are required to
make a more reliable assessment on the HRQOL benefits
for elderly patients undergoing AVR. We recognize the ob-
stacles to performing large randomized controlled trials be-
cause it is unethical to deny patients surgery when operative
morbidity and mortality are excellent. Subsequently, the
strength of evidence reviewed in this article is limited. Yet
there is a burgeoning elderly population, and AVR is in-
creasingly being performed and required in this age group.
This systematic review summarizes the best available evi-
dence on HRQOL after AVR in the elderly.
Summary of Evidence and Interpretation
The main findings of this systematic review are that el-
derly patients have (1) noticeable improvements in cardiac
symptoms after AVR,8,12,15,18,19,21-23,26,29,30,54 (2) equal or
better HRQOL compared with an age-matched general pop-
ulation,12,14,20,23,30,31,53 (3) equivalent or superior HRQOL
compared with younger patients who underwent AVR,23
and (4) significant functional gains after sur-
gery.18,19,21,22,26,28-30
The long-term symptomatic and functional gains afterAVR
in both septuagenarians and octogenarians8,12,15,18,19,21-
23,26,28,29 are important in elderly patients and lead to
a highly positive experience. This is reflected in most or all
patients being satisfied with their decision to undergo
surgery or willing to have another operation.18,19,21,22,26
Elderly patients maintain their HRQOL benefits after
surgery that allow them to have superior HRQOL than their
age-matched counterparts in most studies.12,14,20,23,31,53 Age
seems to be less important in consideration for surgery,
especially when the longer-term HRQOL can be superior to
the level of younger patients.23
The aging population and increasing life expectancy of
patients will lead to continuing increases in degenerative
aortic valve disease, necessitating consideration for AVR.
There is currently no effective medical treatment for aortic
valve lesions. Although there are specific risks of operating
in elderly patients, this must be considered in relation to
benefits for HRQOL. Despite a need for increasing opera-
tions in the elderly, referring physicians may have a percep-
tion of poor outcomes after surgery.7,34 This results in an
increased likelihood of elderly patients being
inadequately managed with conservative treatment.
Patients are likely to have to ongoing symptoms until
a time is demanded for urgent surgery, which is a risk
factor for increased mortality.22
Despite increases in the age of patients undergoing sur-
gery, mortality after AVR is progressively decreasing.56diovascular Surgery c Volume 145, Number 5 1177
TABLE 2. Quality appraisal
Author year (study period) Patients Study design
Methodological quality Precision Overall
vstudy
quality
Validated HRQOL
instrument
Cardiac-specific
measures Patient demographics
Method of follow-up and
HRQOL assessment
Follow-up
consistency
Range/CI/SE/SD
of results
Sundt and colleagues12 2000
(1993-1998)
n ¼ 133 (>80) R Yes; SF-36 Yes; NYHA Male 46.6%, Urgent 10.5%,
Location: United States
Diabetes 17.3%, HTN 67.7%,
Chol NR%
COPD 12%, CRF 5.3% PVD
12.8% CVA 11.3%
Baseline NR
By mail or telephone
Repeat attempts NR
48.9% PR
98% RR
Follow-up: wide
QOL: NR
Excellent
Chiappini and colleagues19
2004 (1982-2003)
n ¼ 115 (>80) R No; own questions Yes; NYHA Male 40.9%, Urgent 14.7%,
Location: Italy
Diabetes 13.8%, HTN 44.9%,
Chol 22.2%
COPD 19.8%, CRF NR%,
PVD NR%, CVA 5.2%
Baseline N/A
By telephone interview
Repeat attempts NR
73.0% PR
100% RR
Follow-up: wide
QOL: moderate
Good
Lam and Hendry23 2004
(1995-1999)
n ¼ 58 (>80) P Yes; SF-36 Yes; NYHA Male 62%, Urgent NR%,
Location: Canada
Diabetes 12%, HTN 35%,
Chol 5%
COPD 7%, CRF 9%, PVD
16%, CVA NR%
Baseline performed
By mail and telephone
Repeat attempts NR
100% PR
35% RR
Follow-up: wide
QOL: NR
Poor
Salazar and colleagues29 2004
(1991-2002)
n ¼ 117 (>70) R No; own questions (NR) Yes; NYHA Male 61.5%, Urgent NR%,
Location: Mexico
Diabetes 14.5%, HTN 43.6%,
Chol NR%
COPD 32.5%, CRF 4.3%,
PVD NR%, CVA 3.4%
Baseline N/A
By NR
Repeat attempts NR
85.5% PR
78% RR
Follow-up: wide
QOL: NR
Poor
Ennker and colleagues20 2006
(1996-2002)
n ¼ 76 (>80)
n ¼ 427 (<80)
R Yes; NHP No; Male 28%, Urgent NR%,
Location: Germany
Diabetes 22%, HTN 53%,
Chol 29%
COPD NR%, CRF 14%, PVD
NR%, CVA NR%
Baseline NR
By mail and telephone
Repeat attempts NR
78.7% PR
77% RR
Follow-up: wide
QOL: narrow
Poor
Kolh and colleagues22 2007
(1992-2004)
n ¼ 220 (>80) R No; own questions Yes; NYHA Male 21%, Urgent 20%,
Location: Sweden
Diabetes 12%, HTN 41%,
Chol 11%
COPD 5%, CRF 4%, PVDNR
%, CVA NA%
Baseline N/A
By clinic visits and annual
letters
Repeat attempts NR
73% PR
99% RR
Follow-up: narrow
QOL: NR
Good
Vicchio and colleagues31 2007
(1988-2005)
n ¼ 681 (>70) R Yes; SF-36 No; Male 43.9%, Urgent 7.6%,
Location: Italy
Diabetes 20.1%, HTN 64%,
Chol NR%
COPD 22.5%, CRF 3.1%,
PVD NR%, CVA NR%
Baseline NR
By outpatient review,
ambulatory clinic,
and telephone interview
Repeat attempts NR
84.9% PR
96.2% RR
Follow-up: wide
QOL: NR
Good
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Vicchio and colleagues53 2008
(1988-2005)
n ¼ 147 (>70) R Yes; SF-36 No; Male 19.7%, Urgent NR%,
Location: Italy
Diabetes 21.2%, HTN 68.6%,
Chol NR%
COPD 20.1%, CRF NR%,
PVD NR%, CVA NR%
Baseline NR
By outpatient review and
telephone interview (late)
Repeat attempts NR
97.8% PR
100% RR
Follow-up: wide
QOL: NR
Poor
Vicchio and colleagues14 2008
(1992-2006)
n ¼ 160 (>80) R Yes; SF-36 No; Bio Prosthesis/mechanical
Prosthesis:
Male 45.6/41.3%, Urgent: NR
%, Location: Italy
Diabetes 26.5/23.9%, HTN
66.2/66.3%, Chol NR%
COPD 32.4/34.8%, CRF 2.9/
4.3%, PVD NR%, CVA
NR%
Baseline NR
By institutional ambulatory
activities
Repeat attempts NR
75.6% PR
97.6% RR
Follow-up: wide
QOL: NR
Good
Maillet and colleagues8 2009
(1998-2001)
n ¼ 84 (>80) R No; own questions Yes; NYHA Male 37%, Urgent NR%,
Location: France
Diabetes NR%, HTN NR%,
Chol NR%
COPD 22.6%, CRF 16.7%,
PVD 20.2%, CVA NR%
Baseline N/A
By telephone interview
Repeat attempts NR
66.7% PR
NR% RR
Follow-up: wide
QOL: NR
Poor
Aoyagi and colleagues18 2010
(1994-2008)
n ¼ 60 (>80)
n ¼ 1387 (<80)
R No; own questions Yes; NYHA Male 38.3%, Urgent 16.7%,
Location: Japan
Diabetes 11.7%, HTN 63.3%,
Chol%
COPD 13.3%, CRF 6.7%,
PVD 20.0%, CVA 26.7%
Baseline N/A
By review of hospital records,
direct patient contact, or
mail
Repeat attempts NR
NR% PR
NR% RR
Follow-up: wide
QOL: NR
Poor
Ferrari and colleagues15 2010
(1990-2005)
n ¼ 124 (>80) R No; own questions Yes; NYHA Male 37%, Urgent 3.0%,
Location: Switzerland
Diabetes 10%, HTN 57%,
Chol 23%
COPD NR%, CRF 22%, PVD
NR%, CVA NR%
Baseline N/A
By NR
Repeat attempts NR
94.4% PR
90% RR
Follow-up: NR
QOL: NR
Poor
Folkmann and colleagues21
2010 (2005-2007)
n ¼ 154 (>80) R No; own questions No; Male 33.8%, Urgent NR%,
Location: Austria
Diabetes 30.3%, HTN NR%,
Chol NR%
COPD 54.9%, CRF 38.7%,
PVD 14.7%, CVA 15.1%
Baseline N/A
By telephone
Repeat attempts NR
81.8% PR
NR% RR
Follow-up: NR
QOL: NR
Poor
Spaziano and colleagues30
2010 (2003-2006)
n ¼ 161 (>80) R Yes; SF-12
MLHFQ
Yes; NYHA Male 50%, Urgent NR%,
Location: Canada
Diabetes NR%, HTN NR%,
Chol NR%
COPD NR%, CRF NR%,
PVD NR%, CVA NR%
Baseline NR
By mail and telephone
Repeat attempts NR
82.6% PR
64.4% RR
Follow-up: moderate
QOL: wide
Poor
Markou and colleagues24 2011 Yes; EuroQOL PDF not sourced*
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TABLE 2. Continued
Author year (study period) Patients Study design
Methodological quality Precision
Overall
vstudy
quality
Validated HRQOL
instrument
Cardiac-specific
measures Patient demographics
Method of follow-up and
HRQOL assessment
Follow-up
consistency
Range/CI/SE/SD
of results
Nikolaidis and colleagues26
2011 (2000-2008)
n ¼ 345 (>80) R No; Yes; NYHA Male 65.5%, Urgent 45.5%,
Location: UK
Diabetes 6.9%, HTN NR%,
Chol NR%
COPD 11.6%, CRF 3.4%,
PVD 3.7%, CVA 4.9%
Baseline N/A
By mail
Repeat attempts NR
81% PR
62% RR
Follow-up: wide
QOL: NR
Poor
Oliveira and colleagues28 2012
(2002-2006)
n ¼ 144 (>75) R No; own questions No; Male 38.6%, Urgent 28.1%,
Location: Portugal
Diabetes 18.4%, HTN 63.2%,
Chol 42.3%
COPD NR%, CRF 57%, PVD
NR%, CVA NR%
Baseline N/A
By telephone interview with
patient or next of kin,
or at outpatient clinic
Repeat attempts NR
76.3% PR
99.1% RR
Follow-up: wide
QOL: NR
Poor
Reynolds and colleagues54
2012 (2007-2009)
n ¼ 216
(TF)
n ¼ 84
(TA)
P Yes; SF-12
EQ-5D
Yes; KCCQ Cohort TF/TA:
Male 55.6%/59.5%, Urgent
NR%, Location: United
States
Diabetes NR%, HTN NR%,
Chol NR%
COPD 7.4%/7.1%, CRF NR
%, PVD 35.7%/62.7%,
CVA 22.7%/29.8%
Baseline performed
By scheduled follow-up visits
or by mail
Repeat attempts N/A
89.8% PR
>80% RR
Follow-up: N/A
QOL: wide
Excellent
Vicchio and colleagues32 2012
(1991-2010)
n ¼ 520 (>70) R Yes; SF-36 No; Group A/B:
Male 42.6/64%, Urgent NR%,
Location: Italy
Baseline NR
By institutional ambulatory
activities
Repeat attempts NR
96.9% PR
98.3% RR
Follow-up: wide
QOL: NR
Good
HRQOL,Health-related quality of life;CI, confidence interval; SE, standard error; SD, standard deviation; R, retrospective; P, prospective; SF-36,Medical Outcomes Survey Short Form 36;NYHA,NewYork Heart Association;HTN,
hypertension;Chol, cholesterol;NR, not recorded;COPD, chronic obstructive pulmonary disease;CRF, chronic renal failure; PVD, peripheral vascular disease;CVA, cerebrovascular accident; PR, participation rate; RR, response rate;
QOL, quality of life; N/A, not applicable; NHP, Nottingham Health Profile; SF-12, Medical Outcomes Survey Short Form 12; MLHFQ, Minnesota Living with Heart Failure Questionnaire; TF, transfemoral cohort; TA, transapical
cohort; KCCQ, Kansas City Cardiomyopathy Questionnaire. *Full PDF document not able to be sourced, hence unable to extract study details such as study period.
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TABLE 3. Results of studies reviewed
Author (year) Objective
Defined as elderly
(mean age, y) Procedures
Comparison group
on generic QOL
Follow-up
interval Conclusions
Sundt and
colleagues12
(2000)
To assess perioperative mortality
and morbidity rates, late
survival and functional
outcome, and HRQOL in
patients aged>80 y
undergoing AVR
80 (83.5  2.6) AVR 26.3%
AVR þ CABG 53.4%
AVR þ MVR 3.0%
Other 17%
General population
(and younger)>75 y
3-18 mo Gratifying late results may be
achieved with AVR in
patients aged>80 y with
excellent results on NYHA
and SF-36. An excellent
HRQOL can be
anticipated in a significant
proportion of elderly
people.
Results: (SF-36, NYHA)
NYHA III/IV 81.2% (preoperative), 20.0% (postoperative). Mean NYHA
functional class improved from 3.1 to 1.7 (P<.001).
Scores on the SF-36 were comparable to those for the general population aged>75 y. Study
patients scored higher than the control population in 5 areas: BP, GH, SF, RE, and MH.
Quantitative results NR.
Chiappini and
colleagues18
(2004)
To analyze whether valve
surgery in
elderly patients can improve
mortality, morbidity, and
HRQOL in otherwise
mentally and physically
healthy patients
80 (82.3  2.1) AVR 62.1%
AVR þ CABG 37.9%
N/A 37.1  32.4 mo Octogenarians with aortic
valve disease should not be
denied the survival and
HRQOL benefits of
surgery if they are
reasonably good surgical
candidates, physically and
mentally able to stand the
stress of surgery, and
motivated to improve their
lifestyle. It is prudent to
avoid delays and risk LV
dysfunction.
Results: (NYHA)
NYHA III/IV 79.3% (preoperative), 5.9% (postoperative). Mean NYHA class improved from
2.90  0.6 to 1.6  0.6 (P<.01).
Some 56.3% and 44.7% rated their activity level as heavy or moderate, respectively; 98% of
patients who underwent AVR were satisfied with their choice.
Lam23 (2004) To investigate the HRQOL after
AVR of patients aged>80 y
compared with that of
younger counterparts to
determine functional
outcomes
80 (83.7  3.4) AVR 52%
AVR þ CABG 48%
General population
aged>75 y
Postoperative vs younger
patients
35.3  25.3 mo Despite higher operative risk
and greater morbidity,
HRQOL indicators in
patients aged  80 y were
equivalent to or better than
their younger
counterparts.Results: (SF-36, NYHA)
NYHA III/IV 38% (preoperative), 3% (postoperative)
Postoperative SF-36 scores, when compared with patients aged<80 y, were better for BP, VT, SF, and MH
(P<.05). When compared with the general population aged 75 y, they were better for BP, GH, VT, SF, and MH (P<.05).
Quantitative results NR.
Salazar and
colleagues29
(2004)
To evaluate the results of AVR in
patients
aged>70 y who underwent
operation at
Instituto Nacional de
Cardiologıa Ignacio Chavez
70 (73.8  3.8) AVR 78.6%
AVR þ CABG 18.8%
AVR þ MVR 2.6%
Preoperative vs
postoperative of
same patients
42.9  33.2 mo In a selected patient
population, AVR in the
elderly is associated with
acceptable mortality and
morbidity. There is
significant lessening of
symptoms and excellent
improvement of HRQOL.
Elderly patients should not
be denied AVR on the
basis of age alone.
Results: (NYHA)
NYHA III/IV 62.4% (preoperative), 0% (postoperative 1 y) 3.8% (postoperative 5 y)
Some 90% of patients resumed normal activities for their age.
(continued)
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TABLE 3. Continued
Author (year) Objective
Defined as elderly
(mean age, y) Procedures
Comparison group
on generic QOL
Follow-up
interval Conclusions
Ennker and
colleagues20
(2006)
To determine whether there
is an increased risk of adverse
perioperative and mid-term
outcome for octogenarians
and whether they benefit
from AVR with stentless
bioprostheses
80 (82  2) AVR 60%
AVR þ CABG 40%
General population
aged>80 y
35  23 mo Because HRQOL and life
expectancy after AVRwith
stentless valves were equal
to the general population,
AVR with stentless
bioprostheses should not
be withheld from
octogenarians.Results: (NHP)
NYHA III/IV 58% (preoperative), NR% (postoperative)
Patients have better NHP scores in 7 of 8 domains (except energy) after AVR with stentless bioprostheses. Women after
AVR and in the general population showed higher scores, indicating a lower QOL.
Quantitative results NR.
Kolh and
colleagues22
(2007)
To assess factors influencing
operative and long-term
outcome in octogenarians
undergoing aortic valve
surgery
80 (82.8  2.4) AVR 74% AVR þ CABG 26% N/A 58.2 mo
Completed
within 2 mo
AVR in octogenarians can be
performed with acceptable
mortality, although
significant morbidity.
These results stress the
importance of early
operation on elderly
patients with aortic valve
disease, avoiding urgent
procedures. Associated
coronary artery disease is
a harbinger of poor
operative outcome. Long-
term symptomatic and
functional recovery are
excellent.
Results: (NYHA)
NYHA III/IV 64% (preoperative), 19% (postoperative)
Some 91% of patients were angina free. The majority of patients were able to undertake moderate or heavy activity (74%);
91% of patients believed that undergoing heart surgery after the age of 80 y was a good choice, and 88% felt as good as
or better than they had preoperatively.
Vicchio and
colleagues31 (2007)
To examine resulting life
expectancy and HRQOLwith
bileaflet mechanical
prostheses with a
centralized management
of anticoagulation in patients
aged>70 y
70 (73  3.3) AVR 77.2%
AVR þ CABG 15.2%
Other 7.6%
Age- and sex-matched
population
4.38  2.85 y Septuagenarian patients
receiving mechanical
valve prostheses did not
experience increased rates
of anticoagulation-related
complications and
perceived a satisfactory
HRQOL.Results: (SF-36)
NYHA III/IV 90.6% (preoperative), NR% (postoperative)
SF-36 scores were significantly higher than those of the age- and sex-matched general Italian population in all domains:
PF 64.4; RP 88.5; BP 96.3; GH 64.5; VT 63.4; SF 79.5; RE 92.6; MH 68.9 (P<.001 in all domains).
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Vicchio and
colleagues53
(2008)
To evaluate LV mass regression,
survival, and HRQOL in
elderly patients after AVR
with small-sized
bileaflet prostheses
70 (NR) AVR (79.6%)
AVR þ CABG (20.4%)
Age-matched general
population
3.9  2.7 y The implantation of 19-mm
bileaflet mechanical
prostheses in the elderly
allowed LV mass
regression and a good
perceived HRQOL.Results: (SF-36)
Scores obtained in the SF-36 test were similar in the 2 groups and significantly higher than those of the general Italian population
matched for age and gender (P<.001 in all domains).
Quantitative results NR.
Vicchio and
colleagues14
(2008)
To determinewhether changes in
prognosis and HRQOL after
AVR in octogenarians differ
depending on the choice of
mechanical or tissue valves
80 (82.3  2.3) AVR 78%-83.7%
AVR þ CABG 16.3%-22%
Age-matched general
population
3.4  2.8 y Considering the similar rates
of early mortality, the very
low rates of valve-related
complications in the
follow-up with both types
of valve substitutes, and
the similar perceived
HRQOL, mechanical
prostheses and tissue
valves can both yield
satisfactory results in
octogenarians.
Results: (SF-36)
NYHA III/IV 70% (preoperative), NR% (postoperative)
Mean scores on each SF-36 scale were satisfactory and comparable in the 2 groups. SF-36 scores were significantly higher than
those in the general Italian population matched for age and sex on 7 of 8 domains: PF (60-70 vs 40-50); RP (80-90 vs 40-50);
BP (90-100 vs 40-50); GH (60-70 vs 40-50); SF (70-80 vs 50-60); RE (80-90 vs 50-60); ME (60-70 vs 40-50). Only VT did
not show a statistical difference.
Quantitative results NR.
Maillet and
colleagues8
(2009)
To evaluate the immediate and
mid-term survival and, most
of all, the frailty of patients
aged>80 y after an AVR
for severe aortic stenosis
80 (83.7  3.3) AVR 58.3%
AVR þ CABG 41.7%
N/A 723  404 d AVR for severe aortic stenosis
can be achieved with an
acceptable postoperative
morbidity and mortality
rate in octogenarians.
There is a good mid-term
survival and relief of
cardiac symptoms, but this
selected elderly population
remains frail as assessed
by the high rate of geriatric
symptoms. Further studies
in octogenarians should
evaluate the impact of
a specific geriatric
management on HRQOL
and frailty after cardiac
surgery.
Results: (NYHA)
NYHA III/IV 82.1% (preoperative), 26.8% (postoperative)
Some 67.9% of patients had a general self-rated health as excellent or good, and 32.1% reported poor or very poor. Some 76.8% of
patients had a self-rated HRQOL that was excellent, very good, or good, and 23.2% reported poor or very poor. Some 66.1% of
patients considered that their health had improved since the operation, and 60.7% of patients would undergo another AVR.
Three important geriatric parameters were studied: gait problems or falls, ADL, and mood disorders. Some 26.8% of
patients experienced a fall at least once during the last year, and 66.1% declared to have gait problems. Only 26.7% needed
help for some of their ADLs, and 0% needed help with all ADLs. Only 8.9% were too dependent to live alone, and 17.8%
thought that their autonomy was worse than before intervention. Half of the population admitted to having sad ideas,
and 33.9% had loss of interest or pleasure.
Self-rated HRQOL was significantly associated with all geriatric parameters and cardiac symptoms (P<.001).
(continued)
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TABLE 3. Continued
Author (year) Objective
Defined as elderly
(mean age, y) Procedures
Comparison group
on generic QOL
Follow-up
interval Conclusions
Aoyagi and
colleagues18
(2010)
To evaluate surgical outcomes
in octogenarian patients
undergoing valve surgery
80 (82.3  1.9) AVR 41.7%
AVR þ CABG 15%
MVR 3.3%
Other 40%
N/A 3.4  3.1 y Valve surgery can be
performed in octogenarian
patients with acceptable
mortality, good long-term
results, and good HRQOL.
Early referral to surgery is
important to obtain a better
postoperative outcome.
Results: (NYHA)
NYHA III/IV 81.7% (preoperative), 0.0% (postoperative)
Some 97.6% of late survivors reported that their activity level was equal to or better than the preoperative level;
29.3% were capable of doing heavy activity (lifting heavy objects); 48.7% were able to do moderate activity (cleaning);
19.5% were able to do light activity (ADLs); and 2.4% were bedridden. All long-term survivors reported their decision
to undergo valve surgery after the age of 80 y was a good choice.
Ferrari and
colleagues15
(2010)
To identify predictive risk
factors for operative results
and to analyze the long-term
survival outcome in
octogenarians operated for
primary isolated AVR
80 (82  2.2) AVR 100% N/A 6.5  NR y Conventional primary,
isolated AVR can be safely
performed in
octogenarians with
acceptable mortality, good
long-term survival, and
good QOL.
In the era of catheter-based
aortic valve implantation,
open surgery for AVR
remains the standard of
care for healthy
octogenarians, and
patients aged>80 y with
mid or low operative risk
should not be denied the
benefit of surgery.
Results: (NYHA)
NYHA III/IV 48% (preoperative), 0.0% (postoperative)
At follow-up, patients were doing well and, in the course of the interview, confirmed a fulfilling HRQOL
comparable to the standard HRQOL of nonoperated octogenarians.
Quantitative results NR.
Folkmann and
colleagues21
(2010)
To identify HRQOL in
octogenarians 1 y after AVR
with or without CABG
80 (82.9  2.5) AVR 46.1%
AVR þ CABG 53.9%
N/A 1 y AVR without CABG is
associated with a good
outcome. The marked
improvement in HRQOL
after 1 y supports the
decision to operate on
patients aged>80 y.
Results: (Own questions)
NYHA III/IV NR% (preoperative), NR% (postoperative)
Some 42% experienced a minimal restriction in their ADLs; 74% experienced less severe symptoms; 18% had the same intensity,
only 8% experienced more severe symptoms after surgery; 5% of patients experienced angina or dyspnea daily, and 52% had
no symptoms. The remaining 43% of patients experienced angina 2 or 3 times per week. Angina did not impair HRQOL in
57% of patients. A further 41% reported mild impairment of their HRQOL, and 2% reported severe restriction of their HRQOL
secondary to heart disease. Some 100% of survivors did not regret undergoing surgery.
Spaziano and
colleagues30
(2010)
To evaluate both long-term
functional status and
HRQOL after valvular
replacement surgery in
octogenarians
80 (80-89) AVR 36.8%
AVR þ CABG 48.7%
Other 14.5%
Age- and gender-matched
general population
Male vs female
2.0  1.1 y Patients aged>80 y benefit
from heart valve
replacement surgery in
terms of both HRQOL and
functional status. Women
may be at increased risk of
a decline in their
emotional well-being and
may benefit more from
convalescence than from
discharge to home.
Results: (SF-12, MLHFQ, NYHA)
NYHA III/IV 67.1% (preoperative), 5% (postoperative). NYHA functional class improved from 2.7 to 1.4 after surgery.
Men showed results similar to those of the age-matched general Canadian population on the PCS and MCS of the SF-12v2.
Women were similar to the general population on the PCS, but their scores were significantly lower on the MCS.
Women discharged to a convalescence resource had significantly better HRQOL scores than those discharged to home
with regard to PCS, the total score of the MLHFQ, and the physical dimension score of the MLHFQ.
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Markou and
colleagues24
(2011)
To investigate changes of
HRQOL at 1 y post-CABG
and post-AVR in patients
aged 70 y
70 AVR 40.4%
CABG 51.6%
Preoperative vs postoperative of
same patients
In elderly patients, HRQOL
strongly increases after
CABG and AVR; however,
the improvement of
functional and social
HRQOL is less for patients
undergoing AVR
compared with CABG.
Results: (EuroQOL)
NYHA III/IV% (preoperative),% (postoperative)
At 1 y postoperatively, the EQ-5D index of the CABG group shows a significant increase, whereas that of the AVR group
does not; however, the EQ-VAS registration shows a significant increase for both the CABG group and AVR group.
The AVR group improved on pain and discomfort item. The CABG group improved in mobility, pain and discomfort, and anxiety.
PDF document unable to be sourced.
Nikolaidis and
colleagues26
(2011)
To analyze the early and long-
term mortality, morbidity,
and HRQOL in patients
aged 80 y who underwent
AVR alone or combined with
CABG
80 (82.9 þ 2.3) AVR 45.5%
AVR þ CABG 51.6%
Other 2.9%
N/A 39.3  29 mo AVR can be undertaken with
excellent results in
octogenarians, and the
current risk is significantly
lower than what is
predicted with
conventional risk-scoring
systems. Patients of
advanced age should not
necessarily be excluded
from being candidates for
AVR.
Results: (NYHA)
NYHA III/IV 56% (preoperative), 12% (postoperative)
The majority of the patients were asymptomatic, whereas 13% were experiencing angina. Some 82% had independent personal care;
88.3% had positive feelings about life; and 82% were happy with their decision to undertake the operation.
Oliveira and
colleagues28
(2012)
To review the long-term survival,
autonomy, and HRQOL of
elderly patients undergoing
AVR
75 (78.5  2.5) AVR
AVR þ CABG
AVR þ MVR
Other
N/A 47.2  23.4 mo At follow-up, most patients
achieved improvement of
HRQOL and remained
autonomous. These results
stress that excellent long-
term outcomes with AVR
can be achieved in
appropriately selected
elderly patients.
Results: (Barthel’s Index)
Some 89.6% of patients were autonomous (BI score 85), whereas a dependent status (BI score 60) was observed in
5.2%; 93.5% of patients confirmed having had an improvement in their HRQOL with AVR, and the remaining recognized that
they had no additional benefit regarding their QOL.
(continued)
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TABLE 3. Continued
Author (year) Objective
Defined as elderly
(mean age, y) Procedures
Comparison group
on generic QOL
Follow-up
interval Conclusions
Reynolds and
colleagues54
(2012)
To compare health status and
HRQOL outcomes for
patients with severe aortic
stenosis and high surgical
risk treated with transcatheter
or surgical AVR
80
TF (84.6  6.5)
TA (83.2  5.9)
AVR 100% Transfemoral transcatheter AVR
Transapical transcatheter AVR
0, 1, 6, 12 mo Both transcatheter and
surgical AVR groups
experienced substantial
improvements at 1 y. This
is despite patients being in
the highest 5% of surgical
risk according to the
Society of Thoracic
Surgeon Series.
Transfemoral
transcatheter AVR may be
associated with a short-
term advantage compared
with surgery.
Results: (SF-12, EQ-5D, KCCQ)
NYHA III/IV NR% (preoperative), NR% (postoperative)
There are great, highly statistically significant, and clinically meaningful HRQOL improvements at 6 and 12 mo.
TF cohort: There are significant benefits for KCCQ summary (P<.001), KCCQ physical limitation (P<.001),
KCCQ total symptoms (P<.001), KCCQ QOL (P<.001), KCCQ social limitations (P<.001), SF-12 physical (P<.001),
SF-12 mental (P ¼ .001), and EQ-5D utility (P<.001) scores up to 12 mo.
TA cohort: There are significant benefits for KCCQ summary (P<.001), KCCQ physical limitation (P ¼ .008), KCCQ total symptoms
(P<.001), KCCQ QOL (P<.001), KCCQ social limitations (P<.001), SF-12 physical (P ¼ .008), and SF-12 mental (P ¼ .02)
scores up to 12 mo.
Please refer to original article for detailed quantitative results.
Vicchio and
colleagues32
(2012)
To evaluate the impact on
survival and HRQOL of
CABG associated with AVR
in septuagenarians and
octogenarians
70 (74.2  3.6) AVR 78.1%
AVR þ CABG 21.9%
Age- and sex-matched general
population
4.2 y Associated CABG determines
a significant increase of
hospital mortality in the
elderly undergoing AVR.
Survivors did not show
differences in long-term
outcome and HRQOL
according to the presence
of associated CABG.
Results: (SF-36)
NYHA III/IVA: 74% B: 74.5% (preoperative), NR% (postoperative)
Elderly patients achieved SF-36 scores higher than the general age- and sex-matched Italian population matched population in all domains
(P<.001): (group A/group B vs general population): PF (66.8/66.6 vs 47.4), RP (86.4/85.8 vs 47.2), BP (93.2/92.7 vs 48.7), GH
(64.5/65.2 vs 42.2), VT (62.4/61.8 vs 44.2), SF (80.8/81.3 vs 59.5), RE (90.7/91.2 vs 52.2), and MH (69.8/70.6 vs 53.3).
QOL, Quality of life; HRQOL, health-related quality of life; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; MVR, mitral valve replacement; NYHA, ew York Heart Association; SF-36,Medical Outcomes
Survey Short Form 36; SF-12,Medical Outcomes Survey Short Form 12; BP, bodily pain; GH, general health; SF, social functioning; RE, role emotional;MH,mental health; T, vitality; LV, left ventricular; NHP,Nottingham Health
Profile; PF, physical functioning; RP, role physical;NR, not recorded;N/A, not applicable; ADL, activities of daily living;MLHFQ,Minnesota Living with Heart Failure Quest nnaire; PCS, physical component summary score;MCS,
mental component summary score; BI, Barthel’s Index; TF, transfemoral cohort; TA, transapical cohort; KCCQ, Kansas City Cardiomyopathy Questionnaire.
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TABLE 4. Early mortality in elderly patients after aortic valve replacement
Study Year Overall early mortality Isolated AVR AVR þ CABG
Studies included in this review
Sundt and colleagues12 2000 11% 8.6% 14.1%
Chiappini and colleagues19 2004 8.5% — —
Lam and Hendry23 2004 8.6% 6.7% 10.7%
Salazar and colleagues29 2004 14.5% — 9.1%
Ennker and colleagues20 2006 6.6% — —
Kolh and colleagues22 2007 13% 9% 24%
Vicchio and colleagues31 2007 11.8% — —
Vicchio and colleagues53 2008 8.8% — —
Vicchio and colleagues14 2008 8.8% 8.5% 10%
Maillet and colleagues8 2009 16.7% 10.2% 25.7%
Aoyagi and colleagues18 2010 13.3% — —
Ferrari and colleagues15 2010 5.6% — —
Folkmann and colleagues21 2010 7.8% 6.8% 8.8%
Spaziano and colleagues30 2010 5.6% — —
Markou and colleagues24 2011 — — —
Nikolaidis and colleagues26 2011 4.9% 4.3% 5.4%
Oliveira28 2012 2.7% — —
Reynolds and colleagues54 2012 — — —
Vicchio and colleagues32 2012 — 7.8% 15.2%
Meta-analysis
Vasques and colleagues2 2012 — 6.7% —
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting.
Shan et al Expert ReviewVasques and colleagues2 recently performed a meta-
analysis of 13,216 patients that showed a low overall
pooled postoperative mortality of 6.7% in octogenarians
undergoing isolated AVR, especially in contemporary se-
ries (5.8% for studies published from 2000 to 2006 and
7.5% for studies published from 1982 to 1999). Given
low levels of early mortality and excellent long-term sur-
vival,2,10,13,57 as well as excellent HRQOL, delay or
exclusion from surgical intervention based solely on age
may deny patients from receiving best practice care. The
risk of surgery is better judged by the presence of
significant comorbidities, such as renal failure, stroke,
and use of an intra-aortic balloon pump.13 Careful selec-
tion of patients based on these factors rather than age re-
sults in good operative outcomes and provides these
patients the chance at significant HRQOL benefits. Some
of the important factors are physical and mental ability
to withstand the stress of surgery and motivation to im-
prove postoperative lifestyle and participate in
rehabilitation.19
Transcatheter aortic valve implantation has been evaluated
for HRQOL benefits, especially in high-risk surgical pa-
tients.58-60 Reynolds and colleagues54 compared the trans-
catheter approach with conventional surgical AVR in the
highest risk surgical patients according to the Society of Tho-
racic Surgeons Series. Both transcatheter implantation and
surgical AVR led to highly statistically significant and clini-
cally meaningful HRQOL benefits. However, data remainThe Journal of Thoracic and Carlimited, and more time is required before this procedure be-
comes an established treatment modality for elderly patients.
The focus is no longer purely about prolonging life, but
rather about improving the HRQOL, which is now a pri-
mary intention of surgery in elderly patients. Elderly pa-
tients themselves are frequently concerned about their
postoperative HRQOL, such as their social and mental
function.17 Information about expected HRQOL allows
these patients to have realistic expectations on physical,
functional, emotional, and mental welfare. This review
demonstrates that there is increasing evidence showing
worthwhile gains in regard to HRQOL after AVR in se-
lected elderly patients.
The patients from the 19 articles reviewed span a wide
range of developed nations: United States, Canada, Ger-
many, France, Italy, Switzerland, Sweden, Austria, United
Kingdom, Australia, Japan, Mexico, and Portugal. Thus,
the results of this systematic review are applicable to all de-
veloped countries. Both elderly patients and their families
can be more confident about the benefits of undergoing
AVR when it is required. Moreover, performing surgery in
the elderly seems to be cost-effective.24 Larger prospective
trials also will be required to further clarify the findings of
this systematic review. Nonetheless, given the increasing
evidence demonstrating good HRQOL after AVR and a rap-
idly increasing elderly population, it is imperative that
healthcare providers can now more confidently provide
AVR to elderly patients.diovascular Surgery c Volume 145, Number 5 1187
Expert Review Shan et alReview Limitations
We aimed to minimize reporting bias with a comprehen-
sive search of the literature for all studies that meet our el-
igibility criteria. Despite using multiple online and hospital
databases, as well as directly e-mailing authors, there was
incomplete retrieval of identified research for 1 article.24
In addition, publication bias may have occurred given that
only published data were assessed.
We acknowledge that the level of evidence of this sys-
tematic review cannot exceed the level of evidence of the
current literature. However, this systematic review adds
substantially to the currently available evidence for elderly
patients being considered for AVR and builds on the conclu-
sions of nonsystematic narrative reviews.27Future Direction
This systematic review revealed a heterogeneous data set
that is difficult to compare and interpret. The subjective na-
ture of HRQOL means a consistent method of investigation
is required. Our recommendations for future studies on
HRQOL after AVR are outlined next.
The most important method of accurately determining
HRQOL is by using previously validated, reliable, and re-
producible HRQOL instruments, such as the SF-36. The
study should have a prospective design with predetermined
follow-up time points to minimize bias, show HRQOL pro-
gression over time, and allow comparison between studies.
Consistent measurements should be performed at baseline;
1 and 6 months; and 1, 2, 3, 4, 5, and 10 years. Telephone
interviews are preferable, and repeated attempts at contact
to minimize loss to follow-up are advisable. Elderly patients
should have their preoperative baseline HRQOL scores
compared with postoperative scores at each time point.
This review demonstrates the benefit of comparing baseline
and postoperativeHRQOL scores with an age-matched gen-
eral population. Because it is unethical to deny patients sur-
gery if they are fit for surgery, it may be possible to compare
patients who received surgery and those who refused or
opted for nonsurgical interventions. To highlight that
HRQOL results are not dependent on age, the change scores
between baseline and postoperative measurements of older
patients can be compared with the change scores of younger
patients. The caveat is that younger patients tend to have ac-
cumulated less comorbidities, so the effect of age can only
be ascertained if patients are matched for comorbidities. Pa-
tients also should be relatively well matched for other char-
acteristics, especially for age and urgency of operation.
Because urgent cardiac operations are associatedwithworse
outcomes and mortality, it would be ideal to conduct studies
purely on patients undergoing elective surgery, who are
more likely to receive AVR in the first place. Finally, multi-
center involvement should be organized to increase patient
numbers and minimize bias from single-center studies.1188 The Journal of Thoracic and Cardiovascular SurCONCLUSIONS
The main findings of this systematic review are that el-
derly patients have (1) improvement in cardiac symptoms
after AVR, (2) equal or better HRQOL compared with an
age-matched general population, (3) equivalent or superior
HRQOL compared with younger patients who underwent
AVR, and (4) significant functional gains after surgery.
We highlight the positive impact of AVR on HRQOL of el-
derly patients. This systematic review should encourage
doctors to evaluate potential patients for AVR surgery on
the basis of their comorbidities rather than using age as
a precluding factor. This review is complete for the current
literature, but we emphasize that in the absence of large ran-
domized controlled trials, this recommendation must be
considered in conjunction with clinical decision-making
tailored to each patient.References
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